Future Retirement Success
  • Politics
  • Business
  • Investing
  • Stocks
  • Politics
  • Business
  • Investing
  • Stocks

Future Retirement Success

Business

Cambridge-based CMR Surgical secures FDA approval for revolutionary portable surgical robot

by October 16, 2024
October 16, 2024
Cambridge-based CMR Surgical secures FDA approval for revolutionary portable surgical robot

CMR Surgical, a Cambridge-based medtech company, has achieved a major breakthrough after receiving marketing authorisation from the US Food and Drug Administration (FDA) for its portable Versius Surgical System.

This marks a significant step into the world’s largest healthcare market, enabling CMR to prepare for sales of the Versius system in the US, initially for gallbladder removal surgeries in adult patients aged 22 and above.

The Versius system, designed to replicate the movements of the human arm and enhance surgeon precision, is already the second-most widely used robotic surgical system globally, with more than 26,000 surgeries completed, including in the UK. This approval comes nearly a decade after CMR Surgical was founded in 2014.

CMR Surgical’s headquarters and manufacturing site remain in Cambridge, with backing from international investors, including the Japanese tech giant SoftBank and China’s Tencent. The company, which has raised approximately $1 billion since its inception, employs over 500 staff, 400 of whom are based in the UK. The company’s $600 million funding round in 2021, led by SoftBank, marked the largest-ever private investment in the global medtech sector.

Mark Slack, CMR’s chief medical officer and co-founder, highlighted the importance of the approval: “Securing FDA marketing authorisation for Versius is a significant milestone for CMR and, most importantly, for hospitals and patients who will now have greater access to robotic-assisted surgery.”

Beyond the US, CMR Surgical is also seeking regulatory approval in other major healthcare markets, including Japan and China.

Although the company had previously considered an initial public offering (IPO), no formal plans have been announced. An IPO remains an option for the future as CMR continues its expansion into key international markets.

Founded in 2014, CMR Surgical has grown rapidly, advancing the accessibility and efficiency of robotic-assisted surgery globally. Its Versius system now stands as a key competitor in the burgeoning market for medical robotics, with the latest FDA approval set to enhance its presence on the global stage.

Read more:
Cambridge-based CMR Surgical secures FDA approval for revolutionary portable surgical robot

0
FacebookTwitterGoogle +Pinterest
previous post
VP Harris to sit down hours from now with Bret Baier for first Fox News interview
next post
Premier Inn owner Whitbread to return £2bn to shareholders as it eyes profit growth and expansion

You may also like

Doncaster Sheffield Airport is closing with the loss...

September 26, 2022

Angling Direct’s sales dry up amid falling water...

August 19, 2022

Small Steps, Big Results: How A Credit Builder...

February 16, 2024

TUC chief defends workers’ rights bill and dismisses...

April 22, 2025

Virgin Orbit ceases operations months after failure of...

May 24, 2023

Reeves rules out Labour raising corporation tax above...

February 2, 2024

Liverpool dock workers to stage two more weeks...

October 15, 2022

UK watchdog to review inflation-busting rises on mobile...

February 10, 2023

The dividing wall between social and traditional media...

September 30, 2022

Billionaire husband of ‘Baroness Bra’ Michelle Mone taking...

January 14, 2024

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • Senate shuts down Kaine’s attempt to check Trump’s war powers

      June 28, 2025
    • 3 Stock Setups for the Second Half of 2025

      June 28, 2025
    • Trump touts administration’s progress on peace deals, says world leaders ‘respect our country again’

      June 27, 2025
    • Venezuelan opposition member details harrowing 400-day captivity at UN

      June 27, 2025
    • Anxious Republicans turn to Trump amid divisions over ‘big, beautiful bill’

      June 27, 2025
    • JD Vance poised to clinch victory for Trump’s landmark bill as GOP finalizes strategy

      June 27, 2025

    Categories

    • Business (8,329)
    • Investing (2,081)
    • Politics (15,842)
    • Stocks (3,176)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: futureretirementsuccess.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 futureretirementsuccess.com | All Rights Reserved